scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051996740 |
P356 | DOI | 10.1186/1471-2407-10-196 |
P932 | PMC publication ID | 2883967 |
P698 | PubMed publication ID | 20462447 |
P5875 | ResearchGate publication ID | 44592097 |
P50 | author | Bernard Debré | Q2897761 |
Nicolas Thiounn | Q114434176 | ||
Annick Vieillefond | Q114718325 | ||
Bin Tean Teh | Q47451223 | ||
P2093 | author name string | Min-Han Tan | |
Tomoaki Fujioka | |||
Stéphane Richard | |||
Kyle A Furge | |||
Ximing J Yang | |||
Philippe Vielh | |||
Daisuke Matsuda | |||
Delphine Amsellem-Ouazana | |||
Marc Zerbib | |||
Thierry Flam | |||
Puay Hoon Tan | |||
Eric Kort | |||
Sophie Giraud | |||
Stéphane Droupy | |||
Gérard Benoît | |||
Sophie Ferlicot | |||
Sok Kean Khoo | |||
Vincent Molinié | |||
Jun Sugimura | |||
Jonathon Ditlev | |||
Chin Fong Wong | |||
Hwei Ling Tan | |||
P2860 | cites work | Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH. | Q48063955 |
Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. | Q50524825 | ||
Birt-Hogg-Dubé syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. | Q55035109 | ||
Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation | Q57631389 | ||
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes | Q74009000 | ||
Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene | Q79387201 | ||
Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization | Q80732556 | ||
Bioconductor: open software development for computational biology and bioinformatics | Q21194861 | ||
Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo | Q24319343 | ||
Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia | Q28118403 | ||
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome | Q28219681 | ||
Characterization of synaptogyrin 3 as a new synaptic vesicle protein | Q28591906 | ||
Diagnosis of multiple cancer types by shrunken centroids of gene expression | Q29615528 | ||
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma | Q29618608 | ||
Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles | Q30939032 | ||
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma | Q34533170 | ||
A molecular classification of papillary renal cell carcinoma | Q34558981 | ||
Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. | Q34587288 | ||
Molecular classification of renal tumors by gene expression profiling | Q35789932 | ||
Gene expression profiling of renal cell carcinoma | Q35901583 | ||
Metastatic renal oncocytoma | Q35954313 | ||
Parafibromin expression in breast cancer: a novel marker for prognostication? | Q38432689 | ||
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma | Q40505781 | ||
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays | Q40559185 | ||
The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct | Q41276062 | ||
Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis | Q42803057 | ||
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers | Q44615414 | ||
Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors | Q44757199 | ||
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma | Q46835332 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | single-nucleotide polymorphism | Q501128 |
chromophobe renal cell carcinoma | Q18556342 | ||
P304 | page(s) | 196 | |
P577 | publication date | 2010-05-12 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma | |
P478 | volume | 10 |
Q49425132 | A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization |
Q64963357 | Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma. |
Q51112302 | Aquaporins in Urinary System. |
Q41626040 | Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms |
Q43127635 | Chromophobe renal cell carcinoma, eosinophilic variant with papillary growth: a case report |
Q46570230 | Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases. |
Q95658401 | Chromophobe renal cell carcinoma: New genetic and metabolic insights |
Q38020180 | Chromophobe renal cell carcinoma: a review of an uncommon entity |
Q61810692 | Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice |
Q27023770 | Circulating biomarkers in advanced renal cell carcinoma: clinical applications |
Q33745315 | Constitutive patterns of gene expression regulated by RNA-binding proteins |
Q83761819 | Copy number profiling in von Hippel-Lindau disease renal cell carcinoma |
Q26752381 | Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma |
Q89184091 | Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC) |
Q34253377 | DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer |
Q36891899 | DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma. |
Q41192211 | Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors |
Q38471131 | Expression analysis of the estrogen receptor target genes in renal cell carcinoma |
Q41766499 | Expression of parafibromin in major renal cell tumors |
Q36640781 | Genetic alterations of HER genes in chromophobe renal cell carcinoma |
Q26785930 | Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms |
Q34295804 | Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma. |
Q50959212 | Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas. |
Q92969752 | Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma |
Q47104226 | Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas |
Q93055320 | Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis |
Q37114357 | Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas |
Q57645130 | Mitochondria with tubulovesicular cristae in renal oncocytomas |
Q92442627 | Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach |
Q33982903 | Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays. |
Q51504223 | Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. |
Q36693159 | Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma |
Q36182819 | Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target? |
Q37836508 | Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities |
Q96132776 | Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab |
Q30248354 | Renal cell cancer: overview of the current therapeutic landscape. |
Q24630685 | State of the science: an update on renal cell carcinoma |
Q27013846 | Targeted therapeutic strategies for the management of renal cell carcinoma |
Q38858757 | The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas |
Q90720037 | Transcriptomics in RCC |